Search Within

Sjoukje Judith Catherina van der Stegen

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (8)
  3. Review (3)
  4. Editorial (1)
Groups
  1. Sloan Kettering Institute Postdocs (26)
  2. Department of Medicine (20)
  3. Hematologic Malignancies, Division of (20)
  4. Center for Hematologic Malignancies (19)
  5. GSK Faculty (19)
  6. Hematologic Malignancies Research (19)

More Groups

People
  1. Michel Sadelain (19)
  2. Isabelle Riviere (12)
  3. Justin Eyquem (10)
  4. Mohamad Hamieh (10)
  5. Jorge Mansilla-Soto (9)
  6. Pieter Lindenbergh (8)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Blood (7)
  2. Cancer Research (3)
  3. Molecular Therapy (3)
  4. Nature (2)
  5. Nature Medicine (2)
  6. Cancer Cell (1)

More Publications

Publishers
  1. Nature Publishing Group (9)
  2. American Society of Hematology (7)
  3. American Association for Cancer Research (4)
  4. Cell Press (2)
  5. Biomed Central Ltd (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive cell therapy from the dish: Potentiating induced pluripotent stem cells
    Review

    Lindenbergh, P. L.; van der Stegen, S. J. C.
    Transfusion Medicine and Hemotherapy (2025)

    Fulltext@MSK | Save
  • The pluripotent path to immunotherapy
    Review

    Diop, M. P.; van der Stegen, S. J. C.
    Experimental Hematology (2024)

    Fulltext@MSK | Save
  • Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
    Review

    Cichocki, F.; van der Stegen, S. J. C.; Miller, J. S.
    Blood (2023)

    Fulltext@MSK | Save
  • Unraveling barriers to iPSC-derived CAR-T cell differentiation
    Editorial

    van der Stegen, S. J. C.; Rivière, I.
    Cell Stem Cell (2023)

    Fulltext@MSK | Save
  • The development of allogeneic tips-derived TCR(-)CAR(+) CD8αβ T cells
    Meeting Abstract

    van der Stegen, S. J. C.; Petrovic, R. M.; Lindenbergh, P. L.; Diop, M. P.; Alexeeva, V.; Xie, H.; Clarke, R.; Valamehr, B.; Rivière, I.; Sadelain, M.
    Blood (2022)

    Fulltext@MSK | Save
  • Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells
    Journal Article

    van der Stegen, S. J. C.; Lindenbergh, P. L.; Petrovic, R. M.; Xie, H.; Diop, M. P.; Alexeeva, V.; Shi, Y.; Mansilla-Soto, J.; Hamieh, M.; Eyquem, J.; more...
    Nature Biomedical Engineering (2022)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors for targeting tumors with low antigen density
    Journal Article

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A. E.; Li, Z.; Sjöstrand, M.; Lindenbergh, P. L.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Combination of three unique anti-tumor modalities engineered into iPSC-derived T cells demonstrate a synergistic effect in overcoming tumor heterogeneity and cancer escape
    Meeting Abstract

    Yang, B. H.; Lin, Y. S. E.; Shirinbak, S.; Yeh, W. I.; Pribadi, M.; Chu, H. Y.; Gutierrez, A.; Mehta, A.; Avramis, E.; Petrovic, R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors effectively target low abundance antigens
    Meeting Abstract

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A.; Li, Z.; Sjöstrand, M.; Lindenbergh, P.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • NOTCH and CAR signaling control T cell lineage commitment from pluripotent stem cells
    Meeting Abstract

    Van der Stegen, S.; Lindenbergh, P.; Petrovic, R.; Whitlock, B.; Clarke, R.; Valamehr, B.; Riviere, I.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save